Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-61.43	23.42	60.72
Graham Fair Price	118.95	1.64	0.75
PEG	-96.72	0.10	-2.96
Price/Book	5.55	4.84	4.58
Price/Cash Flow	100.00	32.38	0.00
Prices/Earnings	-76.44	35.23	149.55
Price/Sales	-46.28	6.06	11.27
Price/FCF	100.00	32.38	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-87.71	0.08	0.63
Operating Margin	0.39	0.03	0.03
ROA	100.00	0.01	0.00
ROE	< 0.005	0.03	348.01
ROIC	0.01	0.03	157.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.53	1.04	97.98
EPS QOQ	-0.51	3.63	618.36
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	-0.48	1.03	114.63
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	3.27	100.00
Days Sales Outstanding (DSO)	0.00	30.47	100.00
Inventory Turnover	0.00	27.55	100.00
Debt/Capitalization	0.00	0.27	100.00
Quick Ratio	0.00	0.47	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.80	1.86	3.44
Cash	0.10	0.20	91.24
Capex	0.00	-0.16	-100.00
Free Cash Flow	0.00	0.28	100.00
Revenue	0.73	1.49	103.23
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	0.52	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.75	3.07	308.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating